Hinge Health Inc. (NYSE:HNGE – Get Free Report) shares hit a new 52-week high on Wednesday. The company traded as high as $126.40 and last traded at $123.3160, with a volume of 78,777 shares changing hands. The stock had previously closed at $123.23.
Analyst Upgrades and Downgrades
HNGE has been the topic of several recent analyst reports. Zacks Research upgraded Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, November 6th. Royal Bank Of Canada raised their price target on Hinge Health from $110.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, November 3rd. Wall Street Zen upgraded Hinge Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Morgan Stanley lifted their price target on Hinge Health from $117.00 to $131.00 and gave the company an “overweight” rating in a research note on Tuesday, November 3rd. Finally, Weiss Ratings raised Hinge Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Hinge Health currently has an average rating of “Buy” and a consensus price target of $118.93.
Read Our Latest Research Report on HNGE
Hinge Health Price Performance
The company’s 50 day moving average is $103.33 and its 200 day moving average is $70.44. The stock has a market cap of $9.77 billion, a price-to-earnings ratio of 61.80, a PEG ratio of 1.72 and a beta of 1.19.
Hinge Health (NYSE:HNGE – Get Free Report) last issued its earnings results on Monday, November 2nd. The company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.44. Hinge Health had a net margin of 21.02% and a return on equity of 66.96%. The company had revenue of $234.97 million for the quarter. During the same quarter in the previous year, the company posted ($0.02) earnings per share. The company’s quarterly revenue was up 52.4% compared to the same quarter last year. Sell-side analysts predict that Hinge Health Inc. will post 1.56 earnings per share for the current year.
Insider Activity at Hinge Health
In other news, President James Pursley sold 33,000 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $94.14, for a total transaction of $3,106,620.00. Following the sale, the president owned 666,909 shares of the company’s stock, valued at $62,782,813.26. The trade was a 4.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 4,100 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $100.20, for a total value of $410,820.00. Following the completion of the sale, the chief executive officer owned 4,100 shares in the company, valued at approximately $410,820. This represents a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,260,488 shares of company stock valued at $124,481,770 in the last 90 days. Insiders own 18.92% of the company’s stock.
Institutional Trading of Hinge Health
Institutional investors have recently bought and sold shares of the company. Global Retirement Partners LLC grew its holdings in Hinge Health by 9,400.0% in the third quarter. Global Retirement Partners LLC now owns 285 shares of the company’s stock valued at $28,000 after purchasing an additional 282 shares during the last quarter. IFP Advisors Inc grew its stake in Hinge Health by 140.0% in the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after acquiring an additional 189 shares during the last quarter. Nykredit A S acquired a new stake in Hinge Health in the 2nd quarter valued at about $29,000. SBI Securities Co. Ltd. grew its stake in Hinge Health by 39.5% in the 3rd quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock valued at $35,000 after acquiring an additional 103 shares during the last quarter. Finally, Allworth Financial LP increased its holdings in Hinge Health by 402.3% during the 3rd quarter. Allworth Financial LP now owns 437 shares of the company’s stock valued at $42,000 after acquiring an additional 350 shares in the last quarter.
Hinge Health Company Profile
Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company’s offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.
Read More
- Five stocks we like better than Hinge Health
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
